1. HBW Insight
  2. >>Ingredients & Safety

CIR Expert Panel’s September Safety Findings, Final 2023 Priorities

 
• By Lauren Nardella and Ryan Nelson

Cosmetic Ingredient Review’s panel of independent experts will be highly focused on botanical ingredients in 2023 – a sign of the times, it says. At its September meeting, the panel finalized six ingredient safety reports, advanced four tentative reports, and issued an insufficient data announcement for Phenyl-Substituted Methicones.

The Expert Panel for Cosmetic Ingredient Safety reached conclusions on six ingredients or ingredient groups at its 26-27 September meeting and finalized its list of priorities for 2023.

The panel’s 162nd meeting could be its last virtual meeting, with plans to convene in-person in December after two years...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Urban Wastewater Directive: AESGP Requests Intervention In EFPIA’s Legal Action

 
• By David Ridley

AESGP has formally submitted a request to the General Court of the European Union to intervene in the European Federation of Pharmaceutical Industries and Association’s legal action against the revised EU Urban Wastewater Directive.

Gardenia Blue, OrangeOvation, StellarYellow Latest Natural Pivots In US Food Color Market

 
• By Malcolm Spicer

FDA’s fourth approval in past two months for color derived from natural sources to use in foods is Gardenia Blue Interest Group’s color additive petition for gardenia blue. Lycored launches StellarYellow and C Clear as alternatives for synthetic dyes yellow Nos. 5 and 6 and OrangeOvation C Clear for

House OMUFA Reauthorization Bill Takes On Clarifying Standards For Tests To Meet GRASE

 
• By Malcolm Spicer

Health Subcommittee will discuss reauthorizing OMUFA during a hearing on how to “maintain and improve” the public health workforce and rural health as well as access to OTC medicines.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By David Ridley

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

More from HBW Insight

Futura Launches Eroxon Strategic Review

 
• By Tom Gallen

Weaker than expected sales of OTC ED treatment Eroxon has led Futura to launch a review of the brand's future direction.

Reducing ‘Complexity Across The Organization’ Tops Kenvue Interim CEO’s Priorities

 
• By Malcolm Spicer

Three weeks into his appointment as interim CEO, Kirk Perry sets priorities including “reduce organizational complexity,” “reinforce a consumer-centric mindset” and “refocus on household penetration.”

E.l.f. Expects Sales To Double On International Growth, Rhode Acquisition

 
• By Eileen Francis

Oakland, Calif.-based e.l.f. Beauty, Inc. says it expects white space opportunities and the Hailey Bieber rhode lifestyle beauty acquisition to more than double its business in coming years.